1. Home
  2. SYM vs IBRX Comparison

SYM vs IBRX Comparison

Compare SYM & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Symbotic Inc.

SYM

Symbotic Inc.

HOLD

Current Price

$40.83

Market Cap

7.5B

Sector

Industrials

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.50

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYM
IBRX
Founded
2005
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
7.2B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SYM
IBRX
Price
$40.83
$7.50
Analyst Decision
Buy
Strong Buy
Analyst Count
12
7
Target Price
$62.50
$12.57
AVG Volume (30 Days)
2.0M
12.2M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.71
EPS
0.03
N/A
Revenue
$2,246,922,000.00
$113,288,000.00
Revenue This Year
$24.75
$88.59
Revenue Next Year
$27.90
$131.15
P/E Ratio
$1,383.00
N/A
Revenue Growth
25.65
668.31
52 Week Low
$38.19
$1.95
52 Week High
$87.88
$12.43

Technical Indicators

Market Signals
Indicator
SYM
IBRX
Relative Strength Index (RSI) 41.78 42.84
Support Level $39.05 $6.69
Resistance Level $57.22 $8.54
Average True Range (ATR) 2.31 0.54
MACD 0.13 -0.16
Stochastic Oscillator 10.22 11.12

Price Performance

Historical Comparison
SYM
IBRX

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: